Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

Executive Summary

Brief summaries of recent developments in the medical device industry.

You may also be interested in...



Strength in Spine

Those venture capitalists and other investors who have been suggesting recently that the spinal device market is overheated, overcrowded, and basically over as a prime investment opportunity were few and far between at Windhover's "In Spine and Orthopedics" conference held in Las Vegas in December. The meeting, which is the largest strategic partnering conference for emerging spine and orthopedic companies, found investors and entrepreneurs feeling bullish about the prospects for the spinal device market, as reflected in the panel discussion excerpted here.

In Women's Health, Hologic Stays Ahead of the Curve

Hologic is garnering more attention these days than it might have in the past because it's just come off an "annus mirabilis." In 2006, Hologic made three vertical acquisitions in the area of breast cancer detection, and it reported stellar financial results. The company is now a market leader in osteoporosis assessment and has an approxmately 50% share of the conventional mammography customer base as well as an early lead in digital mammgoraphy, which is remarkable considering that it is a mid-sized company competing in capital equipment markets against the likes of GE and Siemens.

Spinal Devices: Looking for a Twist Rather than a Tweak

Medical device investors still see great potential in companies developing products to treat the spine. But they're particularly eager to find companies with fresh new approaches toward treatments rather than those that offer a marginal improvement to current products on the market.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035065

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel